Fran Quigley
Fran Quigley is the editor of Faith in Healthcare and director of the Health and Human Rights Clinic at Indiana University McKinney School of Law.
Articles by this author
 |
Views Tuesday, March 24, 2020 "Every Healthcare Worker Is at Risk": A Physician Speaks Out on the Protective Equipment Shortage Last week, Dr. Amy Hale’s schedule treating patients in the Columbus, Indiana Regional Health system included two shifts in special clinics set up to examine and treat persons with upper respiratory problems that could indicate infection with the COVID-19 virus. On Friday, she had a break from... Read more |
 |
Views Monday, March 16, 2020 The Coronavirus Shows It is Time to Remove the For-Profit Infection from U.S. Health Care Last week, I listened as several Indiana workers in the hospitality industry gathered in southeastern Indiana to talk about their health. A cook in her 60s shared how she had gone months without her asthma inhalers because she couldn’t afford them. During that period, she was taken to the hospital... Read more |
 |
Views Sunday, November 24, 2019 How to Win the Holiday Healthcare Debate With Your Conservative Relatives We all know the scenario. The one relative we never see except for holiday family gatherings is holding forth, blasting on high volume political opinions delivered straight from Fox News. Let’s say it’s Uncle Joe at Thanksgiving dinner. He turns to you and says, “Please tell me you are not... Read more |
 |
Views Wednesday, September 18, 2019 Removing the Profit From Our Pills: The Case for a Public Pharma System Any American who has paid the price of a patent-protected medicine knows the core flaw in the U.S. prescription drug system: our elected leaders have handed over control to profit-hungry corporations. And for-profit corporations gonna for-profit, as the kids would say. That is especially true when... Read more |
 |
Views Monday, July 01, 2019 'If Grandma Is on the Table, No One Will Blink at the Price': A Former Drug Company Manager Explains Industry Price-Setting Frances Leath no longer works in management for pharmaceutical industry giant Eli Lilly and Company, but she keeps tabs on the company where she spent the first 15 years of her career. She still lives in Indianapolis, home of the company headquarters. She has watched as Lilly’s dramatic increases... Read more |
 |
Views Thursday, April 25, 2019 American Healthcare Horror Stories: An Incomplete Inventory The statistics demonstrating the scope of our nation’s healthcare crisis are appalling enough. Two of three Americans report skipping needed care each year due to cost, including not filling prescriptions or putting off doctor visits. Millions are forced to borrow money to pay medical bills ,... Read more |
 |
Views Thursday, March 14, 2019 Beating the Big Pharma Shell Game A trillion-dollar industry is in trouble. And it is fighting back. A Harvard-Politico poll taken after the 2018 elections showed that both Republican and Democrat voters cite prescription drug pricing as the top priority for this new Congress. A new Kaiser Family Foundation survey reveals that... Read more |
 |
Views Tuesday, February 09, 2016 Hammer of Justice: Heartland Peace Activist Facing Felonies for Breaking Northrup Grumman Windows Jessica Reznicek, 34, an Iowa peace activist, was arraigned yesterday and charged with two felonies for breaking three windows with a sledgehammer at the Northrup Grumman facility outside the Omaha Nebraska Strategic Air Command at Offut Air Force base. After her court appearance she was returned... Read more |
 |
Views Friday, February 05, 2016 Corporations Killed Medicine. Here’s How to Take It Back. Along the path toward the creation of a global capitalist system, some of the most significant steps were taken by the English enclosure movement. Between the 15 th to 19 th centuries, the rich and the powerful fenced off commonly held land and transformed it into private property. Land switched... Read more |
 |
Views Tuesday, October 13, 2015 Is the TPP the Bull Connor Moment for Access to Medicines? Earlier this month, the representatives of the Trans-Pacific Partnership Agreement (TPP) parties announced they had concluded five years of negotiations by agreeing to final terms . Simply put, the TPP is designed to block the sick and the poor from accessing affordable generic and biosimilar... Read more |